Recursion Pharmaceuticals (NASDAQ:RXRX) Upgraded by Zacks Investment Research to Hold

0
42

Recursion Pharmaceuticals stock has undergone multiple analysts rating changes in the recent past.  Recursion Pharmaceuticals Upgraded by Zacks Investment Research on 10/19/2021. In a note to investors, the firm issued a new rating of Hold. The analysts previously had rating of Sell.

Shares of Recursion Pharmaceuticals traded up $0.21 on Monday, reaching $19.51. 365492 shares of the stock traded hands, compared to its average volume of 769689. Shares of Recursion Pharmaceuticals were trading at $19.51 on Monday. The firm’s 50 day moving average is $22.90 and its 200 day moving average is N/A.Recursion Pharmaceuticals has a 12 month low of $19.26 and a 12 month high of $42.81. While on yearly highs and lows, Recursion Pharmaceuticals’s today has traded high as $19.93 and has touched $19.26 on the downward trend. See More Analyst Rating at: RATING

Recursion Pharmaceuticals Earnings and What to expect: 

Recursion Pharmaceuticals last announced its earnings results on August 12th, 2021. The reported ($0.31) EPS for the quarter, missing analysts’ consensus estimates of ($0.23) by $0.08. The business had revenue of $2.55 million for the quarter, compared to analyst estimates of $2.65 million. Recursion Pharmaceuticals has generated $0.00 earnings per share over the last year. Earnings for Recursion Pharmaceuticals are expected to grow in the coming year, from ($1.35) to ($1.30) per share. Recursion Pharmaceuticals has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Friday, November 12th, 2021 based off prior year’s report dates.

Earnings for Recursion Pharmaceuticals are expected to grow in the coming year, from ($1.35) to ($1.30) per share.

Recursion Pharmaceuticals (NASDAQ:RXRX) Moving Average Technical Analysis

5 day Moving Average is $19.50 And 5 day price change is $1.68 (9.41%)  with average volume for 5 day average is 843,509. While technical analysis for average 20 days shows significant difference, 20 day moving average is  $21.05 and 20 day price change is -$5.94 (-23.31%) and average 20 day moving volume is 636,467. 50 day moving average is $22.90  and 50 day price change is -$8.56 ( -30.46%)  and with average volume for 50 days is : 609,277. 200 day moving average is N/A  and 200 day price change is N/A (N/A)  and with average volume for 200 days is : N/A.

Other owners latest trading in Recursion Pharmaceuticals :

  • On 10/18/2021 shares held by Samson Rock Capital LLP were 10,278 which equates to market value of $0.24M and appx 0.10% owners of Recursion Pharmaceuticals
  • On 10/18/2021 shares held by Nisa Investment Advisors LLC were 2,777 which equates to market value of $64K and appx 0.00% owners of Recursion Pharmaceuticals
  • On 10/13/2021 shares held by Foundations Investment Advisors LLC were 10,247 which equates to market value of $0.22M and appx 0.00% owners of Recursion Pharmaceuticals
  • In total Institutional ownership equates to Institutional Ownership Percentage: 27.58% for Recursion Pharmaceuticals

See More Analyst Rating at: RATING